BPA Call HHSN263201500062B-HHSN26100010

Ended Awarded

Contract number
HHSN26100010
Awardee
Awarding agency
Obligated
$5,791

Award facts

Contract value 100% obligated
$5,790.72 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
334516 Analytical Laboratory Instrument Manufacturing
PSC
J066 Maint/Repair/Rebuild Of Equipment- Instruments And Laboratory Equipment
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20892, USA

Award details come from SAM.gov/FPDS.

About this award

The National Cancer Institute (NCI) awarded a Blanket Purchase Agreement (BPA) call valued at $5,790.72 to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.) on August 25, 2017, with an ultimate completion date of August 31, 2018. This firm fixed-price contract, issued without a small business set-aside, is to be performed in Bethesda, Maryland. As a child entity of Revvity Inc., Revvity Health Sciences specializes in medical imaging products, laboratory equipment, and scientific instrumentation, providing comprehensive procurement and maintenance solutions for specialized scientific equipment used in research and diagnostic applications across federal agencies.

The BPA call represents a task order placed under a larger indefinite delivery vehicle, enabling flexible procurement of equipment and services as needed by the NCI. Revvity Health Sciences maintains an extensive federal contract portfolio with the National Institutes of Health and related institutes, supplying advanced scientific instruments such as imaging systems, cell counters, gamma counters, and mass spectrometers, along with associated maintenance and repair services. This contract supports the NCI's research infrastructure and operational requirements for specialized laboratory equipment necessary to advance cancer research and diagnostic capabilities.

Quick answers

Who was awarded contract HHSN26100010?

HHSN26100010 was awarded to Revvity Health Sciences, Inc. by National Cancer Institute (National Institutes of Health) on August 25, 2017.

How much is contract HHSN26100010 worth?

The government has obligated $5,791 on HHSN26100010.

Is contract HHSN26100010 an order under another contract?

Yes. HHSN26100010 is a BPA call under HHSN263201500062B, a blanket purchase agreement.

Was contract HHSN26100010 competed?

The extent of competition for HHSN26100010 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award